Javascript must be enabled to continue!
536 – Acute Intermittent Porphyria and Cycloid Psychosis
View through CrossRef
Introduction:Acute intermittent porphyria (AIP) is a rare autosomal dominant inherited metabolic disease characterized by mutations in the porphobilinogen deaminase gene. This mutation may provoke neurotoxic levels of delta-aminolevulinic-acid and porphobilinogen, potentially resulting in an acute life-threatening clinical syndrome, characterized by psychiatric, in particular atypical psychotic, symptoms as well as severe neurological and gastrointestinal symptoms. Since the clinical presentation varies and symptoms are nonspecific, diagnosis is often made late.Objectives:Naming of alarm symptoms based on a recent case study.Methods:Description of a recent case supplemented with data from the literature.Results:The patient is a 46 year old woman who was admitted in 2007 with abdominal pain, an epileptic seizure and weakness, interpreted as a Guillain-Barre syndrome. In 2011 she was readmitted with severe abdominal pain, diarrhea, volatile psychotic symptoms and seizures, following a short period of excessive alcohol consumption. During admission she developed progressive weakness in the upper arms, shooting pains in the limbs and a feeling of tightness. Impaired abdominal breathing was suspected. Again, Guillain-Barré syndrome was considered, but additional studies did not support this diagnosis. Because of the recurrent character of symptomatology following alcohol abuse, acute (intermittent) porphyria was considered diagnostically. The dark-colored urine indeed contained significantly increased delta-aminolevulinic-acid and porphobilinogen concentrations. Additional (genetic) diagnosis follows.Conclusion:A recurrent disease course with severe gastrointestinal, neurological and psychiatric symptoms, following alcoholabuse, is suspect for AIP.
Cambridge University Press (CUP)
Title: 536 – Acute Intermittent Porphyria and Cycloid Psychosis
Description:
Introduction:Acute intermittent porphyria (AIP) is a rare autosomal dominant inherited metabolic disease characterized by mutations in the porphobilinogen deaminase gene.
This mutation may provoke neurotoxic levels of delta-aminolevulinic-acid and porphobilinogen, potentially resulting in an acute life-threatening clinical syndrome, characterized by psychiatric, in particular atypical psychotic, symptoms as well as severe neurological and gastrointestinal symptoms.
Since the clinical presentation varies and symptoms are nonspecific, diagnosis is often made late.
Objectives:Naming of alarm symptoms based on a recent case study.
Methods:Description of a recent case supplemented with data from the literature.
Results:The patient is a 46 year old woman who was admitted in 2007 with abdominal pain, an epileptic seizure and weakness, interpreted as a Guillain-Barre syndrome.
In 2011 she was readmitted with severe abdominal pain, diarrhea, volatile psychotic symptoms and seizures, following a short period of excessive alcohol consumption.
During admission she developed progressive weakness in the upper arms, shooting pains in the limbs and a feeling of tightness.
Impaired abdominal breathing was suspected.
Again, Guillain-Barré syndrome was considered, but additional studies did not support this diagnosis.
Because of the recurrent character of symptomatology following alcohol abuse, acute (intermittent) porphyria was considered diagnostically.
The dark-colored urine indeed contained significantly increased delta-aminolevulinic-acid and porphobilinogen concentrations.
Additional (genetic) diagnosis follows.
Conclusion:A recurrent disease course with severe gastrointestinal, neurological and psychiatric symptoms, following alcoholabuse, is suspect for AIP.
Related Results
PERSPECTIVES OF CYCLOID TRANSMISSION
PERSPECTIVES OF CYCLOID TRANSMISSION
In modern mechanical engineering, transmissions with the use of an involute tooth profile are widespread. However, one of the main disadvantages of these transmissions is that they...
Drug-associated Porphyria: A Pharmacovigilance Study
Drug-associated Porphyria: A Pharmacovigilance Study
Abstract
Background: The potentially fatal attacks experienced by carriers of porphyria are triggered by various porphyrinogenic drugs; however, it is difficult to determin...
Cycloid psychosis: revisiting the concept through a case report
Cycloid psychosis: revisiting the concept through a case report
IntroductionThe term cycloid psychosis was first introduced by Karl Kleist in 1926 to describe cases that did not meet the typical presentations of schizophrenia or manic-depressiv...
Acute intermittent porphyria after right hemi-colectomy
Acute intermittent porphyria after right hemi-colectomy
ABSTRACT
Introduction:
Acute intermittent porphyria is a rare autosomal dominant metabolic disease. It is caused by a gen...
The incidence of inherited porphyrias in Europe
The incidence of inherited porphyrias in Europe
AbstractRetrospective estimates of the prevalence of porphyrias have been reported but there has been no large scale prospective study of their incidence. The European Porphyria Ne...
Feasibility of psychosis risk assessment for adolescents diagnosed with autism
Feasibility of psychosis risk assessment for adolescents diagnosed with autism
Autism and psychosis share overlapping clinical features and can occur comorbidly. Given growing recognition that early identification of psychosis risk symptoms may lead to better...
The porphyrias
The porphyrias
Abstract
The porphyrias are a remarkable family of metabolic disorders characterized biochemically by overproduction of haem precursors, principally in the liver ...
Biochemical compared to molecular diagnosis in acute intermittent porphyria
Biochemical compared to molecular diagnosis in acute intermittent porphyria
SummaryThe biochemical and the molecular diagnoses of an inherited porphyria require experience. False positive or negative screening tests and the low penetrance of the disease ma...

